[
  {
    "code": "1",
    "description": "Data Infrastructure and Interoperability for Clinical AI",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing the foundational data systems, standards, and information exchange mechanisms needed to support effective AI deployment in healthcare settings. It includes discussions of longitudinal patient data access, FHIR adoption, data fragmentation across providers, machine-readable policy definitions, and standardized evidence-sharing frameworks. This theme does NOT include cybersecurity concerns (covered separately) or governance/oversight mechanisms (separate theme). The defining characteristic is focus on the underlying data architecture and exchange standards that enable AI systems to function effectively. This matters because commenters consistently identify incomplete or inaccessible data as a root cause of AI failures in clinical settings.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing the foundational data systems, standards, and information exchange mechanisms needed to support effective AI deployment in healthcare settings. It includes discussions of longitudinal patient data access, FHIR adoption, data fragmentation across providers, machine-readable policy definitions, and standardized evidence-sharing frameworks. This theme does NOT include cybersecurity concerns (covered separately) or governance/oversight mechanisms (separate theme). The defining characteristic is focus on the underlying data architecture and exchange standards that enable AI systems to function effectively. This matters because commenters consistently identify incomplete or inaccessible data as a root cause of AI failures in clinical settings.",
    "children": [
      "1.1",
      "1.2",
      "1.3",
      "1.4",
      "1.5"
    ]
  },
  {
    "code": "1.1",
    "description": "Longitudinal Patient Data Access and Completeness. This sub-theme addresses concerns about AI systems lacking access to complete patient histories across care settings and time periods, including proposals for patient-designated data endpoints and persistent routing mechanisms. || It includes requirements for data completeness verification, concerns about temporal gaps in patient records, and the burden placed on patients to bridge data gaps between providers. Excludes real-time data exchange standards (covered in interoperability) and data security requirements (covered in cybersecurity)",
    "level": 2,
    "parent_code": "1",
    "detailed_guidelines": "The key distinction is focus on temporal completeness of individual patient records rather than system-to-system data exchange. This matters because incomplete patient context is cited as a primary driver of AI false positives, false negatives, and bias.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "The key distinction is focus on temporal completeness of individual patient records rather than system-to-system data exchange. This matters because incomplete patient context is cited as a primary driver of AI false positives, false negatives, and bias.",
    "children": []
  },
  {
    "code": "1.2",
    "description": "Patient-Designated Data Endpoints and Aggregation",
    "level": 2,
    "parent_code": "1",
    "detailed_guidelines": "This sub-theme specifically covers proposals for certified endpoints where patients can direct their health data to be aggregated and made accessible to treating providers, with patient agency as the central feature. It includes requirements for security, provenance, auditability, and consent/revocation mechanisms for these endpoints, as well as concerns about current systems requiring patients to actively manage data aggregation. Excludes general patient consent frameworks and provider-controlled data aggregation. The distinguishing feature is patient control over where their longitudinal data resides. This matters because current systems create barriers to complete records that worsen AI performance for patients receiving care across multiple systems.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme specifically covers proposals for certified endpoints where patients can direct their health data to be aggregated and made accessible to treating providers, with patient agency as the central feature. It includes requirements for security, provenance, auditability, and consent/revocation mechanisms for these endpoints, as well as concerns about current systems requiring patients to actively manage data aggregation. Excludes general patient consent frameworks and provider-controlled data aggregation. The distinguishing feature is patient control over where their longitudinal data resides. This matters because current systems create barriers to complete records that worsen AI performance for patients receiving care across multiple systems.",
    "children": []
  },
  {
    "code": "1.3",
    "description": "FHIR and Clinical Data Standards Adoption",
    "level": 2,
    "parent_code": "1",
    "detailed_guidelines": "This sub-theme addresses the acceleration of Fast Healthcare Interoperability Resources (FHIR) and related clinical data standards to enable AI training and real-time clinical use. It includes mandates for bulk data access, mCODE adoption for oncology data, timelines for standards implementation, and concerns about data fragmentation across providers as a key barrier to AI adoption. Excludes evidence-sharing standards and governance-related data requirements. The focus is on core clinical data exchange standards rather than specialized applications. This matters because standardized data access is prerequisite for both AI training and real-time clinical deployment.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the acceleration of Fast Healthcare Interoperability Resources (FHIR) and related clinical data standards to enable AI training and real-time clinical use. It includes mandates for bulk data access, mCODE adoption for oncology data, timelines for standards implementation, and concerns about data fragmentation across providers as a key barrier to AI adoption. Excludes evidence-sharing standards and governance-related data requirements. The focus is on core clinical data exchange standards rather than specialized applications. This matters because standardized data access is prerequisite for both AI training and real-time clinical deployment.",
    "children": []
  },
  {
    "code": "1.4",
    "description": "Evidence-Sharing and Clinical Decision Support Standards. This sub-theme covers standards specifically designed for sharing clinical evidence and decision support information in AI-compatible formats, including the EBMonFHIR Implementation Guide and SummaryOfNetEffect Profile. || It includes requirements for human-readable and machine-interpretable evidence interfaces that present both benefits and harms of recommended interventions. Excludes general clinical data standards and AI output transparency requirements. The distinguishing feature is focus on structured evidence representation rather than raw clinical data",
    "level": 2,
    "parent_code": "1",
    "detailed_guidelines": "This matters because AI-generated recommendations require comprehensive evidence presentation to enable proper clinical evaluation",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This matters because AI-generated recommendations require comprehensive evidence presentation to enable proper clinical evaluation",
    "children": []
  },
  {
    "code": "1.5",
    "description": "Machine-Readable Policy and Semantic Infrastructure",
    "level": 2,
    "parent_code": "1",
    "detailed_guidelines": "This sub-theme addresses proposals for making regulatory and policy information accessible to AI systems in structured, retrievable formats rather than narrative text. It includes deterministic semantic substrates, versioned policy definitions, and authoritative machine-readable policy memory that AI systems can query for compliance verification. Excludes clinical data standards and evidence-sharing frameworks. The key distinction is focus on policy and regulatory content rather than clinical information. This matters because AI systems currently infer policy from narrative text, creating inconsistency and compliance challenges across implementations.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses proposals for making regulatory and policy information accessible to AI systems in structured, retrievable formats rather than narrative text. It includes deterministic semantic substrates, versioned policy definitions, and authoritative machine-readable policy memory that AI systems can query for compliance verification. Excludes clinical data standards and evidence-sharing frameworks. The key distinction is focus on policy and regulatory content rather than clinical information. This matters because AI systems currently infer policy from narrative text, creating inconsistency and compliance challenges across implementations.",
    "children": []
  },
  {
    "code": "10",
    "description": "Equity, Bias, and Access Considerations. This theme encompasses all comments addressing how AI may affect healthcare equity, perpetuate or mitigate bias, and impact access for different populations. || It includes concerns about AI worsening disparities, requirements for bias mitigation, and ensuring AI benefits reach all patients regardless of geography or socioeconomic status. This theme does NOT include general healthcare equity issues unrelated to AI",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "The defining characteristic is focus on differential impacts of AI across populations. This matters because AI deployed without equity considerations may worsen existing healthcare disparities.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "The defining characteristic is focus on differential impacts of AI across populations. This matters because AI deployed without equity considerations may worsen existing healthcare disparities.",
    "children": [
      "10.1",
      "10.2"
    ]
  },
  {
    "code": "10.1",
    "description": "AI Bias and Differential Performance Across Populations. This sub-theme covers concerns about AI systems performing differently across patient populations, including bias worsened for patients receiving care across multiple systems. || It includes requirements for bias mitigation in AI certification and concerns about AI perpetuating historical disparities embedded in training data",
    "level": 2,
    "parent_code": "10",
    "detailed_guidelines": "Excludes access barriers and implementation equity. The focus is on the AI systems themselves rather than deployment patterns. This matters because biased AI may provide worse care for already-disadvantaged populations.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes access barriers and implementation equity. The focus is on the AI systems themselves rather than deployment patterns. This matters because biased AI may provide worse care for already-disadvantaged populations.",
    "children": []
  },
  {
    "code": "10.2",
    "description": "Equitable Access and Implementation Across Settings. This sub-theme addresses ensuring AI benefits reach all patients regardless of geography, socioeconomic status, or care setting, including concerns about inconsistent implementation. || It includes ensuring benefits reach patients regardless of social status and equity as an explicit goal of AI deployment strategy",
    "level": 2,
    "parent_code": "10",
    "detailed_guidelines": "Excludes AI bias and technical performance issues. The distinguishing feature is focus on who receives AI-enabled care rather than how well the AI performs. This matters because AI benefits may accrue primarily to well-resourced patients and institutions without deliberate equity focus.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes AI bias and technical performance issues. The distinguishing feature is focus on who receives AI-enabled care rather than how well the AI performs. This matters because AI benefits may accrue primarily to well-resourced patients and institutions without deliberate equity focus.",
    "children": []
  },
  {
    "code": "11",
    "description": "Patient Agency, Consent, and Trust. This theme encompasses all comments addressing patient rights, consent mechanisms, and trust-building in AI-enabled healthcare, including concerns about AI constraining patient options. It includes consent-driven AI systems, privacy-by-design requirements, patient choice preservation, and concerns about AI limiting rather than expanding treatment options",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing patient rights, consent mechanisms, and trust-building in AI-enabled healthcare, including concerns about AI constraining patient options. It includes consent-driven AI systems, privacy-by-design requirements, patient choice preservation, and concerns about AI limiting rather than expanding treatment options. This theme does NOT include general patient rights or non-AI privacy issues. The defining characteristic is focus on the patient's role and rights in AI-enabled care. This matters because AI must preserve patient agency and build trust to achieve beneficial adoption.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing patient rights, consent mechanisms, and trust-building in AI-enabled healthcare, including concerns about AI constraining patient options. It includes consent-driven AI systems, privacy-by-design requirements, patient choice preservation, and concerns about AI limiting rather than expanding treatment options. This theme does NOT include general patient rights or non-AI privacy issues. The defining characteristic is focus on the patient's role and rights in AI-enabled care. This matters because AI must preserve patient agency and build trust to achieve beneficial adoption.",
    "children": [
      "11.1",
      "11.2"
    ]
  },
  {
    "code": "11.1",
    "description": "Consent and Data Control Mechanisms. This sub-theme covers patient consent requirements and control over how their data is used in AI systems, including consent and revocation mechanisms for data endpoints. || It includes privacy-by-design requirements and patient control over AI access to their information",
    "level": 2,
    "parent_code": "11",
    "detailed_guidelines": "Excludes general privacy regulations and provider data governance. The focus is specifically on patient-controlled consent rather than institutional data policies. This matters because patients must have meaningful control over how AI systems use their health information.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "Excludes general privacy regulations and provider data governance. The focus is specifically on patient-controlled consent rather than institutional data policies. This matters because patients must have meaningful control over how AI systems use their health information.",
    "children": []
  },
  {
    "code": "11.2",
    "description": "Preserving Patient Choice and Treatment Autonomy",
    "level": 2,
    "parent_code": "11",
    "detailed_guidelines": "This sub-theme addresses concerns about AI systems constraining rather than expanding patient options, including requirements that AI preserve physician autonomy and patient agency. It includes concerns about AI optimization inadvertently limiting treatment options that patients would prefer. Excludes consent mechanisms and data control. The distinguishing feature is focus on treatment decisions rather than data use. This matters because AI optimization may inadvertently narrow choices in ways that conflict with patient values and preferences.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses concerns about AI systems constraining rather than expanding patient options, including requirements that AI preserve physician autonomy and patient agency. It includes concerns about AI optimization inadvertently limiting treatment options that patients would prefer. Excludes consent mechanisms and data control. The distinguishing feature is focus on treatment decisions rather than data use. This matters because AI optimization may inadvertently narrow choices in ways that conflict with patient values and preferences.",
    "children": []
  },
  {
    "code": "12",
    "description": "Government Platforms and Federal Leadership. This theme encompasses all comments addressing the role of government in directly providing AI-enabled services or platforms, rather than solely regulating private sector AI. It includes proposals for government-owned healthcare apps, federal leadership in driving AI adoption, and public-private partnership models for national deployment",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing the role of government in directly providing AI-enabled services or platforms, rather than solely regulating private sector AI. It includes proposals for government-owned healthcare apps, federal leadership in driving AI adoption, and public-private partnership models for national deployment. This theme does NOT include regulatory oversight or standard-setting (separate themes). The defining characteristic is focus on government as a direct provider or platform operator rather than regulator. This matters because government platforms may drive market adoption and ensure universal access to AI benefits.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing the role of government in directly providing AI-enabled services or platforms, rather than solely regulating private sector AI. It includes proposals for government-owned healthcare apps, federal leadership in driving AI adoption, and public-private partnership models for national deployment. This theme does NOT include regulatory oversight or standard-setting (separate themes). The defining characteristic is focus on government as a direct provider or platform operator rather than regulator. This matters because government platforms may drive market adoption and ensure universal access to AI benefits.",
    "children": [
      "12.1",
      "12.2"
    ]
  },
  {
    "code": "12.1",
    "description": "Government-Owned Healthcare Applications. This sub-theme covers proposals for federal agencies to develop and operate AI-enabled healthcare applications, including Medicare mobile apps for beneficiaries and providers. || It includes government-controlled platforms as foundations for private sector integration and real-time location tracking and health data capabilities. Excludes regulatory platforms and standard-setting infrastructure",
    "level": 2,
    "parent_code": "12",
    "detailed_guidelines": "The focus is on consumer-facing applications rather than backend systems. This matters because government platforms could drive adoption and reduce fraud while ensuring universal access.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "The focus is on consumer-facing applications rather than backend systems. This matters because government platforms could drive adoption and reduce fraud while ensuring universal access.",
    "children": []
  },
  {
    "code": "12.2",
    "description": "National Demonstration and Operational Scaling Programs. This sub-theme addresses proposals for federally-coordinated AI deployment at operational scale, including shifting from pilots to operational-scale demonstrations. || It includes public-private partnerships for national deployment and coordinated national AI efforts that move beyond small-scale testing",
    "level": 2,
    "parent_code": "12",
    "detailed_guidelines": "Excludes research funding and small-scale pilots. The distinguishing feature is focus on scaling proven approaches rather than testing new ones. This matters because the challenge for healthcare AI is execution at scale, not innovation.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes research funding and small-scale pilots. The distinguishing feature is focus on scaling proven approaches rather than testing new ones. This matters because the challenge for healthcare AI is execution at scale, not innovation.",
    "children": []
  },
  {
    "code": "2",
    "description": "AI Governance Frameworks and Oversight Mechanisms. This theme encompasses all comments addressing how clinical AI should be governed, monitored, and held accountable throughout its lifecycle, from initial deployment through ongoing operation. || It includes governance-first approaches, model-agnostic oversight, socio-technical system perspectives, and debates about appropriate regulatory structures for AI in healthcare",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme does NOT include specific liability frameworks (separate theme) or cybersecurity governance (separate theme). The defining characteristic is focus on the overall approach to AI oversight rather than specific technical or legal mechanisms. This matters because commenters express significant concern about whether current governance approaches are adequate for clinical AI.",
    "comment_count": 5,
    "direct_count": 5,
    "touch_count": 0,
    "detailedDescription": "This theme does NOT include specific liability frameworks (separate theme) or cybersecurity governance (separate theme). The defining characteristic is focus on the overall approach to AI oversight rather than specific technical or legal mechanisms. This matters because commenters express significant concern about whether current governance approaches are adequate for clinical AI.",
    "children": [
      "2.1",
      "2.2",
      "2.3",
      "2.4",
      "2.5",
      "2.6",
      "2.7",
      "2.8"
    ]
  },
  {
    "code": "2.1",
    "description": "Governance-First Versus Adoption-First Sequencing",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This sub-theme addresses the sequencing debate between establishing governance frameworks before versus during AI deployment, including arguments for readiness requirements before reimbursement. It includes concerns about accelerating adoption without adequate safeguards and proposals that governance infrastructure must precede widespread clinical AI use. Excludes specific governance mechanisms and implementation timelines. The key distinction is focus on the temporal relationship between governance and deployment. This matters because premature adoption without governance may externalize harm onto clinicians and patients who lack recourse.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the sequencing debate between establishing governance frameworks before versus during AI deployment, including arguments for readiness requirements before reimbursement. It includes concerns about accelerating adoption without adequate safeguards and proposals that governance infrastructure must precede widespread clinical AI use. Excludes specific governance mechanisms and implementation timelines. The key distinction is focus on the temporal relationship between governance and deployment. This matters because premature adoption without governance may externalize harm onto clinicians and patients who lack recourse.",
    "children": []
  },
  {
    "code": "2.2",
    "description": "Model-Agnostic Governance Through Outputs and Behaviors. This sub-theme covers proposals for governing AI through outputs and behaviors rather than inspecting specific models, including deterministic governance models and audit-by-design outputs. || It includes arguments against model-level inspection as impractical given the opacity and rapid evolution of AI systems. Excludes model-specific certification requirements and technical validation standards. The distinguishing feature is focus on what AI produces rather than how it works internally",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This matters because model inspection is viewed by some as opaque and non-scalable for regulatory purposes",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This matters because model inspection is viewed by some as opaque and non-scalable for regulatory purposes",
    "children": []
  },
  {
    "code": "2.3",
    "description": "Socio-Technical System Perspectives on AI Governance",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This sub-theme addresses arguments that clinical AI should be governed as integrated human-technology systems rather than isolated algorithms, emphasizing workflow integration and organizational context. It includes concerns about how AI reshapes clinical environments, redistribution of accountability within care teams, and the inadequacy of narrow algorithmic focus for real clinical settings. Excludes purely technical governance mechanisms and algorithm-focused validation. The key distinction is emphasis on the human and organizational context of AI deployment. This matters because narrow algorithmic focus may miss critical governance challenges that emerge in actual clinical practice.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses arguments that clinical AI should be governed as integrated human-technology systems rather than isolated algorithms, emphasizing workflow integration and organizational context. It includes concerns about how AI reshapes clinical environments, redistribution of accountability within care teams, and the inadequacy of narrow algorithmic focus for real clinical settings. Excludes purely technical governance mechanisms and algorithm-focused validation. The key distinction is emphasis on the human and organizational context of AI deployment. This matters because narrow algorithmic focus may miss critical governance challenges that emerge in actual clinical practice.",
    "children": []
  },
  {
    "code": "2.4",
    "description": "Algorithm Drift and Performance Degradation Monitoring",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This sub-theme specifically addresses concerns about AI system performance changing over time after deployment, including monitoring requirements for drift detection and triggers for re-validation. It includes concerns about gradual performance degradation as real-world data diverges from training data and the need for ongoing surveillance of AI outputs. Excludes intentional vendor updates and initial validation requirements. The focus is on unintended changes in AI behavior over time. This matters because AI systems may perform differently on real-world data than on training data, with degradation potentially going undetected.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme specifically addresses concerns about AI system performance changing over time after deployment, including monitoring requirements for drift detection and triggers for re-validation. It includes concerns about gradual performance degradation as real-world data diverges from training data and the need for ongoing surveillance of AI outputs. Excludes intentional vendor updates and initial validation requirements. The focus is on unintended changes in AI behavior over time. This matters because AI systems may perform differently on real-world data than on training data, with degradation potentially going undetected.",
    "children": []
  },
  {
    "code": "2.5",
    "description": "Vendor Update and Version Management Governance",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This sub-theme covers governance of changes made by AI vendors to deployed systems, including concerns about updates changing system behavior without adequate provider notification. It includes requirements for version tracking, accountability for vendor-initiated modifications, and concerns that updates may alter AI behavior without triggering re-validation. Excludes algorithm drift and subcontractor issues. The distinguishing feature is focus on intentional vendor changes rather than organic drift. This matters because vendor updates may alter AI behavior in ways that affect patient care without adequate oversight.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers governance of changes made by AI vendors to deployed systems, including concerns about updates changing system behavior without adequate provider notification. It includes requirements for version tracking, accountability for vendor-initiated modifications, and concerns that updates may alter AI behavior without triggering re-validation. Excludes algorithm drift and subcontractor issues. The distinguishing feature is focus on intentional vendor changes rather than organic drift. This matters because vendor updates may alter AI behavior in ways that affect patient care without adequate oversight.",
    "children": []
  },
  {
    "code": "2.6",
    "description": "Subcontractor and Third-Party Access Controls. This sub-theme addresses accountability gaps created when AI vendors use subcontractors or third parties, including concerns about data access and governance of outsourced AI components. || It includes accountability chains across multiple parties and the challenge of maintaining oversight when AI development and operation involves extended supply chains. Excludes direct vendor relationships and internal provider governance",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "The key distinction is focus on extended supply chains rather than primary vendor relationships. This matters because subcontractor access creates accountability gaps that current governance frameworks may not adequately address.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "The key distinction is focus on extended supply chains rather than primary vendor relationships. This matters because subcontractor access creates accountability gaps that current governance frameworks may not adequately address.",
    "children": []
  },
  {
    "code": "2.7",
    "description": "Deterministic and Auditable AI Output Requirements. This sub-theme covers requirements for AI systems to produce consistent, verifiable, and auditable outputs that enable compliance verification and accountability enforcement. || It includes deterministic governance models, decision provenance requirements, and audit-by-design approaches that create durable records of AI operations. Excludes transparency requirements focused on explanation rather than auditability",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "The defining characteristic is focus on verifiability and consistency of outputs rather than interpretability. This matters because auditable outputs are prerequisite for meaningful oversight and enforcement.",
    "comment_count": 3,
    "direct_count": 3,
    "touch_count": 0,
    "detailedDescription": "The defining characteristic is focus on verifiability and consistency of outputs rather than interpretability. This matters because auditable outputs are prerequisite for meaningful oversight and enforcement.",
    "children": []
  },
  {
    "code": "2.8",
    "description": "Ethical Oversight and Bioethics Integration",
    "level": 2,
    "parent_code": "2",
    "detailed_guidelines": "This sub-theme addresses the role of ethics review and bioethics expertise in AI governance, including proposals for engaging federal bioethics resources and Presidential-level bioethics commissions. It includes partnering with non-federal ethics organizations and concerns that ethical considerations may be insufficiently emphasized in current AI initiatives. Excludes technical governance mechanisms and liability frameworks. The focus is specifically on ethical dimensions rather than technical or legal oversight. This matters because commenters express concern that rapid AI deployment may outpace ethical deliberation.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the role of ethics review and bioethics expertise in AI governance, including proposals for engaging federal bioethics resources and Presidential-level bioethics commissions. It includes partnering with non-federal ethics organizations and concerns that ethical considerations may be insufficiently emphasized in current AI initiatives. Excludes technical governance mechanisms and liability frameworks. The focus is specifically on ethical dimensions rather than technical or legal oversight. This matters because commenters express concern that rapid AI deployment may outpace ethical deliberation.",
    "children": []
  },
  {
    "code": "3",
    "description": "Accountability, Liability, and Contestability Frameworks. This theme encompasses all comments addressing who is responsible when AI-influenced decisions cause harm and how affected parties can seek remedy through legal and procedural mechanisms. || It includes liability allocation between vendors and providers, safe harbors for validated AI, contestability pathways, and decision provenance requirements. This theme does NOT include general governance approaches (separate theme) or transparency requirements (separate theme)",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "The defining characteristic is focus on legal responsibility and remedy mechanisms. This matters because unclear accountability is cited as a major barrier to AI adoption and a risk for harm externalization.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "The defining characteristic is focus on legal responsibility and remedy mechanisms. This matters because unclear accountability is cited as a major barrier to AI adoption and a risk for harm externalization.",
    "children": [
      "3.1",
      "3.2",
      "3.3",
      "3.4",
      "3.5"
    ]
  },
  {
    "code": "3.1",
    "description": "Clinician Liability Protection and Safe Harbors",
    "level": 2,
    "parent_code": "3",
    "detailed_guidelines": "This sub-theme specifically addresses proposals to protect healthcare providers from liability when using validated or certified AI tools, including safe harbor mechanisms and HHS-certified AI tools. It includes conditions under which clinicians should be shielded from AI-related liability and concerns that liability uncertainty discourages adoption of potentially beneficial tools. Excludes vendor liability and patient remedy mechanisms. The distinguishing feature is focus on protecting clinicians rather than allocating responsibility to other parties. This matters because liability concerns prevent clinicians from adopting AI tools even when they could improve patient care.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme specifically addresses proposals to protect healthcare providers from liability when using validated or certified AI tools, including safe harbor mechanisms and HHS-certified AI tools. It includes conditions under which clinicians should be shielded from AI-related liability and concerns that liability uncertainty discourages adoption of potentially beneficial tools. Excludes vendor liability and patient remedy mechanisms. The distinguishing feature is focus on protecting clinicians rather than allocating responsibility to other parties. This matters because liability concerns prevent clinicians from adopting AI tools even when they could improve patient care.",
    "children": []
  },
  {
    "code": "3.2",
    "description": "Vendor Accountability and Disclaimer Limitations. This sub-theme addresses concerns about AI vendors avoiding responsibility through disclaimers and contractual limitations, including arguments against allowing vendor disclaimers to shield accountability. || It includes requirements for vendors to bear responsibility for AI failures, concerns about \"responsibility laundering,\" and the risk that disclaimers may leave no accountable party when AI causes harm",
    "level": 2,
    "parent_code": "3",
    "detailed_guidelines": "Excludes clinician liability and patient contestability. The key distinction is focus on vendor obligations rather than user protections. This matters because vendor disclaimers may create accountability gaps that harm patients without recourse.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes clinician liability and patient contestability. The key distinction is focus on vendor obligations rather than user protections. This matters because vendor disclaimers may create accountability gaps that harm patients without recourse.",
    "children": []
  },
  {
    "code": "3.3",
    "description": "Decision Provenance and Audit Trail Requirements. This sub-theme addresses requirements for recording the inputs, processes, and outputs of AI-influenced decisions to enable later review and challenge. || It includes recording inputs, model versions, confidence levels, downstream actions, and accountable authorities for each AI-influenced decision",
    "level": 2,
    "parent_code": "3",
    "detailed_guidelines": "Excludes general transparency requirements and liability frameworks. The focus is specifically on creating durable records that enable contestability. This matters because meaningful challenge rights require evidence of what the AI system did and why.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes general transparency requirements and liability frameworks. The focus is specifically on creating durable records that enable contestability. This matters because meaningful challenge rights require evidence of what the AI system did and why.",
    "children": []
  },
  {
    "code": "3.4",
    "description": "Challenge Procedures and Binding Timelines. This sub-theme covers the procedural requirements for patients and clinicians to contest AI-driven outcomes, including standard pathways for challenges and binding deadlines for responses. || It includes escalation procedures, requirements for meaningful review, and concerns that without enforceable procedures contestability rights may be meaningless in practice",
    "level": 2,
    "parent_code": "3",
    "detailed_guidelines": "Excludes decision provenance and liability allocation. The distinguishing feature is focus on the process of challenging rather than the evidence needed. This matters because transparency without enforceable contestability is viewed as insufficient protection for affected parties.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "Excludes decision provenance and liability allocation. The distinguishing feature is focus on the process of challenging rather than the evidence needed. This matters because transparency without enforceable contestability is viewed as insufficient protection for affected parties.",
    "children": []
  },
  {
    "code": "3.5",
    "description": "Human Oversight and Functional Override Capability",
    "level": 2,
    "parent_code": "3",
    "detailed_guidelines": "This sub-theme addresses requirements for meaningful human control over AI-influenced decisions, including defining \"human oversight\" as functional override capability rather than nominal review. It includes concerns about performative \"human-in-the-loop\" claims and requirements for system design that enables actual intervention. Excludes general governance approaches and liability frameworks. The key distinction is focus on the practical ability to override AI rather than nominal review requirements. This matters because \"human-in-the-loop\" language may be performative if system design prevents meaningful intervention.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses requirements for meaningful human control over AI-influenced decisions, including defining \"human oversight\" as functional override capability rather than nominal review. It includes concerns about performative \"human-in-the-loop\" claims and requirements for system design that enables actual intervention. Excludes general governance approaches and liability frameworks. The key distinction is focus on the practical ability to override AI rather than nominal review requirements. This matters because \"human-in-the-loop\" language may be performative if system design prevents meaningful intervention.",
    "children": []
  },
  {
    "code": "4",
    "description": "Regulatory Clarity and Agency Coordination. This theme encompasses all comments addressing the need for clearer regulatory guidance and better coordination among federal agencies overseeing clinical AI, including FDA, ONC, and CMS. It includes FDA approval requirements, distinctions between regulated and unregulated AI tools, and coordination between HHS agencies",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing the need for clearer regulatory guidance and better coordination among federal agencies overseeing clinical AI, including FDA, ONC, and CMS. It includes FDA approval requirements, distinctions between regulated and unregulated AI tools, and coordination between HHS agencies. This theme does NOT include specific governance mechanisms (separate theme) or liability frameworks (separate theme). The defining characteristic is focus on regulatory clarity and inter-agency alignment. This matters because navigating current regulations is cited as a significant barrier to introducing safe AI tools.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing the need for clearer regulatory guidance and better coordination among federal agencies overseeing clinical AI, including FDA, ONC, and CMS. It includes FDA approval requirements, distinctions between regulated and unregulated AI tools, and coordination between HHS agencies. This theme does NOT include specific governance mechanisms (separate theme) or liability frameworks (separate theme). The defining characteristic is focus on regulatory clarity and inter-agency alignment. This matters because navigating current regulations is cited as a significant barrier to introducing safe AI tools.",
    "children": [
      "4.1",
      "4.2",
      "4.3"
    ]
  },
  {
    "code": "4.1",
    "description": "FDA Approval Requirements and Regulatory Scope",
    "level": 2,
    "parent_code": "4",
    "detailed_guidelines": "This sub-theme covers questions about which AI products require FDA approval and how approval requirements should be clarified, including distinguishing clinical AI tools requiring approval from those that do not. It includes concerns about regulatory navigation challenges for AI developers and healthcare organizations seeking to deploy AI tools. Excludes ONC certification and CMS reimbursement requirements. The focus is specifically on FDA's regulatory scope rather than other agency requirements. This matters because lack of clarity on FDA requirements creates uncertainty that may delay beneficial AI deployment.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers questions about which AI products require FDA approval and how approval requirements should be clarified, including distinguishing clinical AI tools requiring approval from those that do not. It includes concerns about regulatory navigation challenges for AI developers and healthcare organizations seeking to deploy AI tools. Excludes ONC certification and CMS reimbursement requirements. The focus is specifically on FDA's regulatory scope rather than other agency requirements. This matters because lack of clarity on FDA requirements creates uncertainty that may delay beneficial AI deployment.",
    "children": []
  },
  {
    "code": "4.2",
    "description": "Autonomous AI Systems and Future Standards Development",
    "level": 2,
    "parent_code": "4",
    "detailed_guidelines": "This sub-theme addresses the need for proactive development of standards for AI systems that operate without human clinician involvement, before such tools become widespread. It includes concerns that current frameworks don't address autonomous medical decision-making and calls for standards development to anticipate future capabilities. Excludes current human-in-the-loop AI governance and existing FDA requirements. The distinguishing feature is focus on future autonomous systems rather than current AI tools. This matters because autonomous AI will require compliance standards that don't yet exist.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the need for proactive development of standards for AI systems that operate without human clinician involvement, before such tools become widespread. It includes concerns that current frameworks don't address autonomous medical decision-making and calls for standards development to anticipate future capabilities. Excludes current human-in-the-loop AI governance and existing FDA requirements. The distinguishing feature is focus on future autonomous systems rather than current AI tools. This matters because autonomous AI will require compliance standards that don't yet exist.",
    "children": []
  },
  {
    "code": "4.3",
    "description": "Multi-Stakeholder and Federal-State Alignment",
    "level": 2,
    "parent_code": "4",
    "detailed_guidelines": "This sub-theme covers the need for coordination among federal agencies, states, healthcare organizations, and other stakeholders to ensure consistent AI implementation. It includes unified frameworks for AI implementation, alignment of expectations across jurisdictions, and concerns about inconsistent implementation creating inequities. Excludes specific agency requirements and international alignment. The key distinction is focus on domestic coordination rather than specific regulatory requirements. This matters because inconsistent AI implementation across geographies and delivery systems may create disparities in care quality.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers the need for coordination among federal agencies, states, healthcare organizations, and other stakeholders to ensure consistent AI implementation. It includes unified frameworks for AI implementation, alignment of expectations across jurisdictions, and concerns about inconsistent implementation creating inequities. Excludes specific agency requirements and international alignment. The key distinction is focus on domestic coordination rather than specific regulatory requirements. This matters because inconsistent AI implementation across geographies and delivery systems may create disparities in care quality.",
    "children": []
  },
  {
    "code": "5",
    "description": "Clinical Workflow Integration and Usability. This theme encompasses all comments addressing how AI tools fit into real clinical practice and affect healthcare delivery, including the gap between theoretical benefits and real-world implementation. It includes workflow compatibility, clinician burden, practical usability concerns, and the importance of designing AI for actual clinical environments",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing how AI tools fit into real clinical practice and affect healthcare delivery, including the gap between theoretical benefits and real-world implementation. It includes workflow compatibility, clinician burden, practical usability concerns, and the importance of designing AI for actual clinical environments. This theme does NOT include technical performance or validation (separate theme) or governance mechanisms (separate theme). The defining characteristic is focus on the practical experience of using AI in clinical settings. This matters because AI adoption succeeds or fails based on practical realities, not theoretical benefits.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing how AI tools fit into real clinical practice and affect healthcare delivery, including the gap between theoretical benefits and real-world implementation. It includes workflow compatibility, clinician burden, practical usability concerns, and the importance of designing AI for actual clinical environments. This theme does NOT include technical performance or validation (separate theme) or governance mechanisms (separate theme). The defining characteristic is focus on the practical experience of using AI in clinical settings. This matters because AI adoption succeeds or fails based on practical realities, not theoretical benefits.",
    "children": [
      "5.1",
      "5.2",
      "5.3"
    ]
  },
  {
    "code": "5.1",
    "description": "Workflow Compatibility and EMR Integration",
    "level": 2,
    "parent_code": "5",
    "detailed_guidelines": "This sub-theme covers concerns about whether AI tools fit into existing clinical workflows and processes, including EMR integration and timing of AI recommendations within care processes. It includes disruption to established clinical routines and the challenge of inserting AI recommendations at appropriate decision points. Excludes administrative burden and clinician training. The focus is on how AI fits into the flow of clinical work rather than the effort required to use it. This matters because tools that don't fit real workflows will not be adopted regardless of their technical capabilities.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers concerns about whether AI tools fit into existing clinical workflows and processes, including EMR integration and timing of AI recommendations within care processes. It includes disruption to established clinical routines and the challenge of inserting AI recommendations at appropriate decision points. Excludes administrative burden and clinician training. The focus is on how AI fits into the flow of clinical work rather than the effort required to use it. This matters because tools that don't fit real workflows will not be adopted regardless of their technical capabilities.",
    "children": []
  },
  {
    "code": "5.2",
    "description": "Clinician Burden and Alert Fatigue",
    "level": 2,
    "parent_code": "5",
    "detailed_guidelines": "This sub-theme addresses whether AI tools reduce or increase the burden on healthcare providers, including concerns about AI adding rather than reducing work. It includes documentation requirements, alert fatigue from excessive AI notifications, and the goal of burden reduction as a success metric for AI deployment. Excludes workflow compatibility and training requirements. The distinguishing feature is focus on net workload impact rather than workflow fit. This matters because AI that increases burden will face resistance and may worsen clinician burnout rather than alleviating it.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses whether AI tools reduce or increase the burden on healthcare providers, including concerns about AI adding rather than reducing work. It includes documentation requirements, alert fatigue from excessive AI notifications, and the goal of burden reduction as a success metric for AI deployment. Excludes workflow compatibility and training requirements. The distinguishing feature is focus on net workload impact rather than workflow fit. This matters because AI that increases burden will face resistance and may worsen clinician burnout rather than alleviating it.",
    "children": []
  },
  {
    "code": "5.3",
    "description": "Workforce Readiness and Capacity Planning",
    "level": 2,
    "parent_code": "5",
    "detailed_guidelines": "This sub-theme covers the relationship between AI deployment and healthcare workforce capacity, including Workforce Readiness Telemetry proposals and using AI to predict clinical capacity degradation. It includes AI as deflationary infrastructure that could help address systemic workforce shortages if properly deployed. Excludes training requirements and workflow integration. The key distinction is focus on workforce-level capacity rather than individual clinician burden. This matters because AI may help address systemic workforce shortages but requires deliberate planning to achieve this benefit.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers the relationship between AI deployment and healthcare workforce capacity, including Workforce Readiness Telemetry proposals and using AI to predict clinical capacity degradation. It includes AI as deflationary infrastructure that could help address systemic workforce shortages if properly deployed. Excludes training requirements and workflow integration. The key distinction is focus on workforce-level capacity rather than individual clinician burden. This matters because AI may help address systemic workforce shortages but requires deliberate planning to achieve this benefit.",
    "children": []
  },
  {
    "code": "6",
    "description": "Transparency and Explainability Requirements. This theme encompasses all comments addressing requirements for AI systems to be understandable and their operations visible to users and oversight bodies. || It includes transparency requirements, explainability standards, and concerns about opaque AI systems undermining clinical judgment",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme does NOT include auditability requirements (covered in governance) or contestability mechanisms (covered in accountability). The defining characteristic is focus on understanding AI operations rather than challenging or auditing them. This matters because lack of transparency undermines trust and prevents meaningful clinical judgment.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This theme does NOT include auditability requirements (covered in governance) or contestability mechanisms (covered in accountability). The defining characteristic is focus on understanding AI operations rather than challenging or auditing them. This matters because lack of transparency undermines trust and prevents meaningful clinical judgment.",
    "children": [
      "6.1",
      "6.2"
    ]
  },
  {
    "code": "6.1",
    "description": "Clinical Decision Support Evidence Presentation",
    "level": 2,
    "parent_code": "6",
    "detailed_guidelines": "This sub-theme covers requirements for AI-generated clinical recommendations to be understandable by healthcare providers, including comprehensive evidence presentation and balanced reporting of benefits and harms. It includes concerns about selective one-sided justifications that don't provide clinicians with the information needed to exercise judgment. Excludes technical model explainability and patient-facing transparency. The focus is on what clinicians need to understand to evaluate AI recommendations. This matters because AI may generate recommendations without providing the evidence needed for proper clinical evaluation.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers requirements for AI-generated clinical recommendations to be understandable by healthcare providers, including comprehensive evidence presentation and balanced reporting of benefits and harms. It includes concerns about selective one-sided justifications that don't provide clinicians with the information needed to exercise judgment. Excludes technical model explainability and patient-facing transparency. The focus is on what clinicians need to understand to evaluate AI recommendations. This matters because AI may generate recommendations without providing the evidence needed for proper clinical evaluation.",
    "children": []
  },
  {
    "code": "6.2",
    "description": "Model Cards and AI Documentation Standards. This sub-theme addresses standardized documentation requirements for AI systems, including model cards, AI Bills of Materials, and \"nutrition labels\" for clinical AI. || It includes documentation of training data sources, intended use cases, known limitations, and performance characteristics across populations. Excludes real-time decision explanations and evidence presentation",
    "level": 2,
    "parent_code": "6",
    "detailed_guidelines": "The distinguishing feature is focus on static documentation rather than dynamic explanations. This matters because standardized documentation enables comparison and evaluation of AI tools before deployment.",
    "comment_count": 0,
    "direct_count": 0,
    "touch_count": 0,
    "detailedDescription": "The distinguishing feature is focus on static documentation rather than dynamic explanations. This matters because standardized documentation enables comparison and evaluation of AI tools before deployment.",
    "children": []
  },
  {
    "code": "7",
    "description": "Cybersecurity and AI-Specific Threats. This theme encompasses all comments addressing security vulnerabilities, threats, and protective measures specific to AI systems in healthcare, including novel attack vectors. || It includes encrypted blind spots, autonomous agentic malware, data pipeline vulnerabilities, and AI-based defensive solutions. This theme does NOT include general healthcare cybersecurity or data privacy (separate considerations)",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "The defining characteristic is focus on security challenges unique to or amplified by AI systems. This matters because AI creates new attack surfaces and threat paradigms that traditional security approaches cannot address.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "The defining characteristic is focus on security challenges unique to or amplified by AI systems. This matters because AI creates new attack surfaces and threat paradigms that traditional security approaches cannot address.",
    "children": [
      "7.1",
      "7.2",
      "7.3",
      "7.4",
      "7.5"
    ]
  },
  {
    "code": "7.1",
    "description": "Device Identification and Network Visibility Challenges",
    "level": 2,
    "parent_code": "7",
    "detailed_guidelines": "This sub-theme covers the challenge of identifying AI-enabled devices on healthcare networks, including encrypted blind spots that mask device identity. It includes standardized identification mechanisms, public APIs for device verification, and cryptographic identification keys to verify legitimate devices. Excludes general network security and data encryption requirements. The focus is specifically on the visibility problem created by encrypted AI devices. This matters because hospitals cannot verify if devices are legitimate or compromised when encryption masks identity.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers the challenge of identifying AI-enabled devices on healthcare networks, including encrypted blind spots that mask device identity. It includes standardized identification mechanisms, public APIs for device verification, and cryptographic identification keys to verify legitimate devices. Excludes general network security and data encryption requirements. The focus is specifically on the visibility problem created by encrypted AI devices. This matters because hospitals cannot verify if devices are legitimate or compromised when encryption masks identity.",
    "children": []
  },
  {
    "code": "7.2",
    "description": "AI-Powered Attack Vectors and Threat Landscape",
    "level": 2,
    "parent_code": "7",
    "detailed_guidelines": "This sub-theme addresses emerging threats that specifically target or exploit AI systems in healthcare, including autonomous agentic malware and prompt injection attacks. It includes reinforcement learning by attackers and real-world examples like ServiceNow \"BodySnatcher\" and Silver Fox targeting medical imaging. Excludes traditional cybersecurity threats and general malware. The distinguishing feature is focus on threats that leverage or target AI capabilities. This matters because attackers are using AI to find defensive gaps and hijacking the AI tools hospitals depend on.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses emerging threats that specifically target or exploit AI systems in healthcare, including autonomous agentic malware and prompt injection attacks. It includes reinforcement learning by attackers and real-world examples like ServiceNow \"BodySnatcher\" and Silver Fox targeting medical imaging. Excludes traditional cybersecurity threats and general malware. The distinguishing feature is focus on threats that leverage or target AI capabilities. This matters because attackers are using AI to find defensive gaps and hijacking the AI tools hospitals depend on.",
    "children": []
  },
  {
    "code": "7.3",
    "description": "Training Data Poisoning and Pipeline Security",
    "level": 2,
    "parent_code": "7",
    "detailed_guidelines": "This sub-theme covers vulnerabilities in AI training data and data pipelines that could compromise clinical outputs, including poisoned training data and compromised data sources. It includes the need to extend security requirements to AI model dependencies and concerns about integrity of data used to train and update AI. Excludes runtime security and network-level threats. The key distinction is focus on the integrity of training data rather than operational security. This matters because poisoned training data leads to compromised AI decisions that may not be detectable through output monitoring.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers vulnerabilities in AI training data and data pipelines that could compromise clinical outputs, including poisoned training data and compromised data sources. It includes the need to extend security requirements to AI model dependencies and concerns about integrity of data used to train and update AI. Excludes runtime security and network-level threats. The key distinction is focus on the integrity of training data rather than operational security. This matters because poisoned training data leads to compromised AI decisions that may not be detectable through output monitoring.",
    "children": []
  },
  {
    "code": "7.4",
    "description": "AI-Based Defensive Capabilities and Response Speed",
    "level": 2,
    "parent_code": "7",
    "detailed_guidelines": "This sub-theme addresses the need for AI-powered security solutions to counter AI-based threats, including autonomous detection and response capabilities. It includes matching defensive speed to attacker speed and Continuous Threat Exposure Management requirements. Excludes traditional security measures and human-speed response approaches. The focus is on using AI defensively rather than just securing AI systems. This matters because human-speed responses are inadequate against AI-powered attacks that operate at machine speed.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the need for AI-powered security solutions to counter AI-based threats, including autonomous detection and response capabilities. It includes matching defensive speed to attacker speed and Continuous Threat Exposure Management requirements. Excludes traditional security measures and human-speed response approaches. The focus is on using AI defensively rather than just securing AI systems. This matters because human-speed responses are inadequate against AI-powered attacks that operate at machine speed.",
    "children": []
  },
  {
    "code": "7.5",
    "description": "AI Asset Inventory and Dynamic Tracking",
    "level": 2,
    "parent_code": "7",
    "detailed_guidelines": "This sub-theme covers requirements for tracking and managing AI systems as security-relevant assets, including extending Relevant Electronic Information Systems definitions to AI. It includes real-time discovery of AI models, version tracking, and AI Bills of Materials for security purposes. Excludes general IT asset management and non-AI device inventory. The distinguishing feature is focus on the unique inventory challenges posed by AI systems in ephemeral containers and cloud environments. This matters because static inventory approaches cannot track dynamic AI assets that may change frequently.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers requirements for tracking and managing AI systems as security-relevant assets, including extending Relevant Electronic Information Systems definitions to AI. It includes real-time discovery of AI models, version tracking, and AI Bills of Materials for security purposes. Excludes general IT asset management and non-AI device inventory. The distinguishing feature is focus on the unique inventory challenges posed by AI systems in ephemeral containers and cloud environments. This matters because static inventory approaches cannot track dynamic AI assets that may change frequently.",
    "children": []
  },
  {
    "code": "8",
    "description": "Reimbursement, Incentives, and Payment Alignment. This theme encompasses all comments addressing how payment structures and financial incentives should support or govern AI adoption in healthcare. It includes CMS reimbursement mechanisms, value-based care integration, CPT codes for AI services, and alignment of payment with desired outcomes",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing how payment structures and financial incentives should support or govern AI adoption in healthcare. It includes CMS reimbursement mechanisms, value-based care integration, CPT codes for AI services, and alignment of payment with desired outcomes. This theme does NOT include general healthcare financing or non-AI payment issues. The defining characteristic is focus on financial mechanisms specifically related to AI adoption and use. This matters because misaligned financial incentives are cited as a barrier to beneficial AI adoption.",
    "comment_count": 2,
    "direct_count": 2,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing how payment structures and financial incentives should support or govern AI adoption in healthcare. It includes CMS reimbursement mechanisms, value-based care integration, CPT codes for AI services, and alignment of payment with desired outcomes. This theme does NOT include general healthcare financing or non-AI payment issues. The defining characteristic is focus on financial mechanisms specifically related to AI adoption and use. This matters because misaligned financial incentives are cited as a barrier to beneficial AI adoption.",
    "children": [
      "8.1",
      "8.2",
      "8.3"
    ]
  },
  {
    "code": "8.1",
    "description": "New CPT Codes and Payment Mechanisms for AI Services. This sub-theme covers proposals for specific reimbursement codes and payment structures for AI-enabled services, including new CPT codes for AI-enabled trial matching and care coordination. || It includes reimbursement tied to verified data delivery and payment for AI-generated services that currently lack billing pathways. Excludes value-based care integration and general payment reform",
    "level": 2,
    "parent_code": "8",
    "detailed_guidelines": "The focus is on creating new payment pathways rather than modifying existing ones. This matters because lack of reimbursement mechanisms prevents adoption of beneficial AI applications.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "The focus is on creating new payment pathways rather than modifying existing ones. This matters because lack of reimbursement mechanisms prevents adoption of beneficial AI applications.",
    "children": []
  },
  {
    "code": "8.2",
    "description": "Value-Based Care and AI Integration",
    "level": 2,
    "parent_code": "8",
    "detailed_guidelines": "This sub-theme addresses how AI should be incorporated into value-based payment models and quality programs, including integrating AI utilization into APMs and MIPS. It includes rewarding cost-deflation through AI-enabled efficiencies and aligning payment with burden reduction outcomes. Excludes fee-for-service payment and new CPT codes. The distinguishing feature is focus on value-based frameworks rather than service-specific payment. This matters because value-based models can create incentives for AI adoption that improves outcomes and reduces costs.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses how AI should be incorporated into value-based payment models and quality programs, including integrating AI utilization into APMs and MIPS. It includes rewarding cost-deflation through AI-enabled efficiencies and aligning payment with burden reduction outcomes. Excludes fee-for-service payment and new CPT codes. The distinguishing feature is focus on value-based frameworks rather than service-specific payment. This matters because value-based models can create incentives for AI adoption that improves outcomes and reduces costs.",
    "children": []
  },
  {
    "code": "8.3",
    "description": "Governance Readiness Requirements Before Reimbursement",
    "level": 2,
    "parent_code": "8",
    "detailed_guidelines": "This sub-theme covers proposals to condition AI reimbursement on demonstrated organizational readiness, including governance requirements before payment. It includes readiness assessments and concerns about paying for AI before organizations can use it safely. Excludes payment amounts and value-based integration. The key distinction is focus on prerequisites for payment rather than payment mechanisms themselves. This matters because reimbursement without readiness requirements may incentivize premature or unsafe AI adoption.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers proposals to condition AI reimbursement on demonstrated organizational readiness, including governance requirements before payment. It includes readiness assessments and concerns about paying for AI before organizations can use it safely. Excludes payment amounts and value-based integration. The key distinction is focus on prerequisites for payment rather than payment mechanisms themselves. This matters because reimbursement without readiness requirements may incentivize premature or unsafe AI adoption.",
    "children": []
  },
  {
    "code": "9",
    "description": "Clinical Trial Access and AI-Enabled Matching. This theme encompasses all comments addressing the use of AI to improve patient access to clinical trials and research opportunities, particularly for patients who currently learn about trials too late. It includes trial-first AI pathways, AI-generated trial matching, prior authorization exceptions for trials, and concerns about delayed trial access",
    "level": 1,
    "parent_code": null,
    "detailed_guidelines": "This theme encompasses all comments addressing the use of AI to improve patient access to clinical trials and research opportunities, particularly for patients who currently learn about trials too late. It includes trial-first AI pathways, AI-generated trial matching, prior authorization exceptions for trials, and concerns about delayed trial access. This theme does NOT include general AI clinical applications or research on AI itself. The defining characteristic is focus on using AI to connect patients with clinical trials. This matters because most patients learn about clinical trials too late, after prior authorization delays or disease progression.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This theme encompasses all comments addressing the use of AI to improve patient access to clinical trials and research opportunities, particularly for patients who currently learn about trials too late. It includes trial-first AI pathways, AI-generated trial matching, prior authorization exceptions for trials, and concerns about delayed trial access. This theme does NOT include general AI clinical applications or research on AI itself. The defining characteristic is focus on using AI to connect patients with clinical trials. This matters because most patients learn about clinical trials too late, after prior authorization delays or disease progression.",
    "children": [
      "9.1",
      "9.2"
    ]
  },
  {
    "code": "9.1",
    "description": "Trial-First AI Pathways and Prior Authorization Integration",
    "level": 2,
    "parent_code": "9",
    "detailed_guidelines": "This sub-theme covers proposals to use AI to identify trial eligibility before standard treatment authorization processes, including AI-generated trial reports prior to prior authorization. It includes \"gold card\" mechanisms for real-time approval and treating trial enrollment as a prior-authorization exception. Excludes general prior authorization reform and non-trial AI applications. The focus is specifically on the intersection of trial matching and authorization processes. This matters because current processes delay trial access until after patients have progressed or exhausted other options.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme covers proposals to use AI to identify trial eligibility before standard treatment authorization processes, including AI-generated trial reports prior to prior authorization. It includes \"gold card\" mechanisms for real-time approval and treating trial enrollment as a prior-authorization exception. Excludes general prior authorization reform and non-trial AI applications. The focus is specifically on the intersection of trial matching and authorization processes. This matters because current processes delay trial access until after patients have progressed or exhausted other options.",
    "children": []
  },
  {
    "code": "9.2",
    "description": "Trial Matching Infrastructure and National Coordination",
    "level": 2,
    "parent_code": "9",
    "detailed_guidelines": "This sub-theme addresses the operational infrastructure needed for AI-enabled trial matching at scale, including hub-and-spoke infrastructure and public-private partnerships. It includes national coordination of trial matching and leveraging existing infrastructure that requires policy support to scale. Excludes payment mechanisms and regulatory requirements. The distinguishing feature is focus on operational capacity rather than policy frameworks. This matters because infrastructure exists to implement trial matching but requires coordinated policy support to achieve national scale.",
    "comment_count": 1,
    "direct_count": 1,
    "touch_count": 0,
    "detailedDescription": "This sub-theme addresses the operational infrastructure needed for AI-enabled trial matching at scale, including hub-and-spoke infrastructure and public-private partnerships. It includes national coordination of trial matching and leveraging existing infrastructure that requires policy support to scale. Excludes payment mechanisms and regulatory requirements. The distinguishing feature is focus on operational capacity rather than policy frameworks. This matters because infrastructure exists to implement trial matching but requires coordinated policy support to achieve national scale.",
    "children": []
  }
]